Emergent canine visceral leishmaniasis in Argentina: Comparative diagnostics and relevance to proliferation of human disease.

<h4>Background</h4>Visceral leishmaniasis (VL) is a zoonotic protozoal vector-borne disease that is a major public health challenge. In Argentina, canine (CVL) and human visceral leishmaniasis (HVL) have recently emerged. There is a lack of standardised diagnostic tests for CVL, which hi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kyoko Fujisawa, Charlotte Silcott-Niles, Poppy Simonson, Daniela Lamattina, Cristian A Humeres, Tapan Bhattacharyya, Pascal Mertens, Caroline Thunissen, Victoria O'Rourke, Magdalena Pańczuk, James A Whitworth, Oscar Daniel Salomón, Michael A Miles
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Acceso en línea:https://doaj.org/article/8c658952271a4e2f94123426c5c8c7b0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8c658952271a4e2f94123426c5c8c7b0
record_format dspace
spelling oai:doaj.org-article:8c658952271a4e2f94123426c5c8c7b02021-12-02T20:23:45ZEmergent canine visceral leishmaniasis in Argentina: Comparative diagnostics and relevance to proliferation of human disease.1935-27271935-273510.1371/journal.pntd.0009552https://doaj.org/article/8c658952271a4e2f94123426c5c8c7b02021-07-01T00:00:00Zhttps://doi.org/10.1371/journal.pntd.0009552https://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735<h4>Background</h4>Visceral leishmaniasis (VL) is a zoonotic protozoal vector-borne disease that is a major public health challenge. In Argentina, canine (CVL) and human visceral leishmaniasis (HVL) have recently emerged. There is a lack of standardised diagnostic tests for CVL, which hinders control of CVL and HVL.<h4>Methodology/principal findings</h4>Sampling was carried out in Puerto Iguazú, Argentina, comprising 190 asymptomatic, oligosymptomatic and polysymptomatic dogs. The following diagnostics were applied: microscopy of lymph node aspirate (LNA); three immunochromatographic rapid diagnostic tests (RDTs), prototype rK28-ICT, rK39-ICT (both Coris BioConcept), commercial rK39 (InBios); ELISA for IgG, IgG1 and IgG2, against rK28, rK39 or crude lysate antigen. DNA detection and analysis, with 30 dogs, was of the ITS1 region using skin samples, and loop-mediated isothermal amplification (LAMP; Eiken Loopamp) of buffy coat, skin scrape or LNA. 15.4% of dogs were positive by LNA microscopy. The rK28 RDT had higher seropositivity rate (61%) than either a prototype rK39 RDT (31.4%) or commercial rK39 RDT (18.8%), without cross-reactivity with six other pathogens. IgG anti-rK39 ELISA antibody titres, but not IgG2, were positively correlated with number of clinical signs. LAMP with LNA had a higher positivity rate than PCR; buffy coat sampling was more sensitive than skin scrape. ITS1 confirmed Leishmania (Leishmania) infantum as the agent of CVL. Leishmania (Viannia) spp. was detected in skin samples from two dogs, compatible with Leishmania (Viannia) braziliensis.<h4>Conclusions/significance</h4>Seroprevalence confirmed rapid increase in CVL in Puerto Iguazú. The rK28 RDT test potentially has great value for improved point-of-care diagnosis. Given cost reduction and accessibility, commercial LAMP may be applicable to buffy coat. RDT biomarkers of CVL clinical status are required to combat spread of CVL and HVL. The presence of Viannia, perhaps as an agent of human mucocutaneous leishmaniasis (MCL), highlights the need for vigilance and surveillance.Kyoko FujisawaCharlotte Silcott-NilesPoppy SimonsonDaniela LamattinaCristian A HumeresTapan BhattacharyyaPascal MertensCaroline ThunissenVictoria O'RourkeMagdalena PańczukJames A WhitworthOscar Daniel SalomónMichael A MilesPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 15, Iss 7, p e0009552 (2021)
institution DOAJ
collection DOAJ
language EN
topic Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
spellingShingle Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
Kyoko Fujisawa
Charlotte Silcott-Niles
Poppy Simonson
Daniela Lamattina
Cristian A Humeres
Tapan Bhattacharyya
Pascal Mertens
Caroline Thunissen
Victoria O'Rourke
Magdalena Pańczuk
James A Whitworth
Oscar Daniel Salomón
Michael A Miles
Emergent canine visceral leishmaniasis in Argentina: Comparative diagnostics and relevance to proliferation of human disease.
description <h4>Background</h4>Visceral leishmaniasis (VL) is a zoonotic protozoal vector-borne disease that is a major public health challenge. In Argentina, canine (CVL) and human visceral leishmaniasis (HVL) have recently emerged. There is a lack of standardised diagnostic tests for CVL, which hinders control of CVL and HVL.<h4>Methodology/principal findings</h4>Sampling was carried out in Puerto Iguazú, Argentina, comprising 190 asymptomatic, oligosymptomatic and polysymptomatic dogs. The following diagnostics were applied: microscopy of lymph node aspirate (LNA); three immunochromatographic rapid diagnostic tests (RDTs), prototype rK28-ICT, rK39-ICT (both Coris BioConcept), commercial rK39 (InBios); ELISA for IgG, IgG1 and IgG2, against rK28, rK39 or crude lysate antigen. DNA detection and analysis, with 30 dogs, was of the ITS1 region using skin samples, and loop-mediated isothermal amplification (LAMP; Eiken Loopamp) of buffy coat, skin scrape or LNA. 15.4% of dogs were positive by LNA microscopy. The rK28 RDT had higher seropositivity rate (61%) than either a prototype rK39 RDT (31.4%) or commercial rK39 RDT (18.8%), without cross-reactivity with six other pathogens. IgG anti-rK39 ELISA antibody titres, but not IgG2, were positively correlated with number of clinical signs. LAMP with LNA had a higher positivity rate than PCR; buffy coat sampling was more sensitive than skin scrape. ITS1 confirmed Leishmania (Leishmania) infantum as the agent of CVL. Leishmania (Viannia) spp. was detected in skin samples from two dogs, compatible with Leishmania (Viannia) braziliensis.<h4>Conclusions/significance</h4>Seroprevalence confirmed rapid increase in CVL in Puerto Iguazú. The rK28 RDT test potentially has great value for improved point-of-care diagnosis. Given cost reduction and accessibility, commercial LAMP may be applicable to buffy coat. RDT biomarkers of CVL clinical status are required to combat spread of CVL and HVL. The presence of Viannia, perhaps as an agent of human mucocutaneous leishmaniasis (MCL), highlights the need for vigilance and surveillance.
format article
author Kyoko Fujisawa
Charlotte Silcott-Niles
Poppy Simonson
Daniela Lamattina
Cristian A Humeres
Tapan Bhattacharyya
Pascal Mertens
Caroline Thunissen
Victoria O'Rourke
Magdalena Pańczuk
James A Whitworth
Oscar Daniel Salomón
Michael A Miles
author_facet Kyoko Fujisawa
Charlotte Silcott-Niles
Poppy Simonson
Daniela Lamattina
Cristian A Humeres
Tapan Bhattacharyya
Pascal Mertens
Caroline Thunissen
Victoria O'Rourke
Magdalena Pańczuk
James A Whitworth
Oscar Daniel Salomón
Michael A Miles
author_sort Kyoko Fujisawa
title Emergent canine visceral leishmaniasis in Argentina: Comparative diagnostics and relevance to proliferation of human disease.
title_short Emergent canine visceral leishmaniasis in Argentina: Comparative diagnostics and relevance to proliferation of human disease.
title_full Emergent canine visceral leishmaniasis in Argentina: Comparative diagnostics and relevance to proliferation of human disease.
title_fullStr Emergent canine visceral leishmaniasis in Argentina: Comparative diagnostics and relevance to proliferation of human disease.
title_full_unstemmed Emergent canine visceral leishmaniasis in Argentina: Comparative diagnostics and relevance to proliferation of human disease.
title_sort emergent canine visceral leishmaniasis in argentina: comparative diagnostics and relevance to proliferation of human disease.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/8c658952271a4e2f94123426c5c8c7b0
work_keys_str_mv AT kyokofujisawa emergentcaninevisceralleishmaniasisinargentinacomparativediagnosticsandrelevancetoproliferationofhumandisease
AT charlottesilcottniles emergentcaninevisceralleishmaniasisinargentinacomparativediagnosticsandrelevancetoproliferationofhumandisease
AT poppysimonson emergentcaninevisceralleishmaniasisinargentinacomparativediagnosticsandrelevancetoproliferationofhumandisease
AT danielalamattina emergentcaninevisceralleishmaniasisinargentinacomparativediagnosticsandrelevancetoproliferationofhumandisease
AT cristianahumeres emergentcaninevisceralleishmaniasisinargentinacomparativediagnosticsandrelevancetoproliferationofhumandisease
AT tapanbhattacharyya emergentcaninevisceralleishmaniasisinargentinacomparativediagnosticsandrelevancetoproliferationofhumandisease
AT pascalmertens emergentcaninevisceralleishmaniasisinargentinacomparativediagnosticsandrelevancetoproliferationofhumandisease
AT carolinethunissen emergentcaninevisceralleishmaniasisinargentinacomparativediagnosticsandrelevancetoproliferationofhumandisease
AT victoriaorourke emergentcaninevisceralleishmaniasisinargentinacomparativediagnosticsandrelevancetoproliferationofhumandisease
AT magdalenapanczuk emergentcaninevisceralleishmaniasisinargentinacomparativediagnosticsandrelevancetoproliferationofhumandisease
AT jamesawhitworth emergentcaninevisceralleishmaniasisinargentinacomparativediagnosticsandrelevancetoproliferationofhumandisease
AT oscardanielsalomon emergentcaninevisceralleishmaniasisinargentinacomparativediagnosticsandrelevancetoproliferationofhumandisease
AT michaelamiles emergentcaninevisceralleishmaniasisinargentinacomparativediagnosticsandrelevancetoproliferationofhumandisease
_version_ 1718374119232241664